EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Chikungunya virus seroprevalence among febrile patients in selected health facilities in Mount Elgon region, Kenya

Sheila Kageha iD, Joyce Mwongeli Ngoi, Toru Kubo, Kouichi Morita, Moses Matilu Mwau

PLOS Neglected Tropical Diseases · 2025

DOI: 10.1371/journal.pntd.0012169 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2025. Verfasst von Sheila Kageha und 4 weiteren Autor:innen. Beteiligte Einrichtung: Kenya Medical Research Institute, Nairobi, Kenya. Hauptthemen laut MEDLINE: Chikungunya Fever, Antibodies, Viral, Chikungunya virus, Fever. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chikungunya is an emerging vector-borne disease of global significance, known for causing acute illness characterized by fever and severe arthralgia, which can evolve to chronic arthritis and rheumatism especially in elderly patients. While febrile illness and arthralgia are common clinical presentations among residents of Mount Elgon (Mt. Elgon), the role of chikungunya virus as a causative agent is undocumented. This study aimed to assess the prevalence of antibodies against Chikungunya Virus (CHIKV) antigens in patients presenting with acute febrile illnesses (AFI) in Mt. Elgon region, Kenya.

Methods

This cross-sectional seroprevalence study involved febrile patients visiting selected health facilities in the region. Serum samples were collected and screened for 1gG + IgM + IgA antibodies using an indirect Enzyme Linked Immunosorbent Assay (ELISA). Positive samples were further analyzed using standard plaque reduction neutralization assay (PRNT) on Vero (Biken) E6 cell cultures for confirmation of presence of neutralizing antibodies against CHIKV.

Results

ELISA results indicated that 317/1359 (23.33%) serum samples were positive for CHIKV antibodies. Of these, 305 samples (96.21%) were subjected to PRNT, 127 samples (9.3%) tested positive for CHIKV neutralizing antibodies.

Conclusion

These findings indicate active circulation of CHIKV in Mt. Elgon region. This underscores the need for enhanced surveillance and monitoring strategies to mitigate the risk of potential outbreaks in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chikungunya FeverAntibodies, ViralChikungunya virusFeverHumansSeroepidemiologic StudiesKenyaMaleFemaleCross-Sectional StudiesAdultMiddle AgedAdolescentYoung AdultAgedChildEnzyme-Linked Immunosorbent AssayAntibodies, NeutralizingChild, PreschoolHealth FacilitiesAged, 80 and overAnimalsChlorocebus aethiopsImmunoglobulin M

Substanzen

Antibodies, ViralAntibodies, NeutralizingImmunoglobulin MImmunoglobulin G

Autor:innen und Institutionen

  • Kenya Medical Research Institute, Nairobi, Kenya.
  • University of Ghana College of Basic and Applied Sciences, Centre for Cell Biology of Infectious Pathogens (WACCBIP), Accra, Ghana.
  • Nagasaki University, Institute of Tropical Medicine, Nagasaki, Japan.

ORCID-Profile: Sheila Kageha

Zitieren

APA

Kageha, S., Ngoi, J. M., Kubo, T., Morita, K., & Mwau, M. M. (2025). Chikungunya virus seroprevalence among febrile patients in selected health facilities in Mount Elgon region, Kenya. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0012169

Vancouver

Kageha S, Ngoi JM, Kubo T, Morita K, Mwau MM. Chikungunya virus seroprevalence among febrile patients in selected health facilities in Mount Elgon region, Kenya. PLOS Neglected Tropical Diseases. 2025. doi:10.1371/journal.pntd.0012169

BibTeX
@article{Kageha2025,
  author = {Kageha, Sheila and Ngoi, Joyce Mwongeli and Kubo, Toru and Morita, Kouichi and Mwau, Moses Matilu},
  title = {Chikungunya virus seroprevalence among febrile patients in selected health facilities in Mount Elgon region, Kenya},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2025},
  doi = {10.1371/journal.pntd.0012169}
}
Kostenlos starten →